Chemical Nametafluprost
Dosage FormSolution (topical; 0.0015%)
Drug ClassOphthalmic agents
CompanyMerck & Co.
Approval Year2012


  • Indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Last updated on 4/19/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Zioptan (tafluprost) Prescribing Information.2012Merck & Co., Inc., Whitehouse Station
Document TitleYearSource
Primary open-angle glaucoma preferred practice pattern.2020American Academy of Ophthalmology